Form 4 Filing for BridgeBio Pharma, Inc.

This filing details a Form 4 filing for BridgeBio Pharma, Inc. (BBIO) concerning transactions by Ronald J. Daniels, a director. On June 22, 2026, Mr. Daniels was granted 3,990 shares of Common Stock and 5,277 Stock Options. The Common Stock grant is part of the Issuer's 2021 Amended and Restated Stock Option and Incentive Plan and vests on June 22, 2027, contingent upon continued service. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The Stock Options also vest in full on June 22, 2027, subject to continued service. The reported transactions indicate a direct ownership nature.